Mycophenolic Acid Tablet, Delayed Release
Product Images NDC 72789-246

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Mycophenolic Acid (NDC 72789-246). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72789246 Label (72789246)

Each delayed-release film coated tablet contains mycophenolate sodium equivalent to 360mg mycophenolic acid. It is important to keep the medication dispensed in a tight container and out of reach of children. The medication should be stored in a controlled room temperature, between 15°C and 30°C. Dispensing should be done according to the prescriptions insert. The medication should not be used if the inner foil seal is missing or broken. The product should be protected from moisture. The package is controlled by PD-Rx Pharmaceuticals and is available only by prescription.*

FDA Label Image

72789247 Label (72789247)

This is a medication containing mycophenolate sodium equivalent to 180 mg mycophenolic acid in each tablet. It is a delayed-release tablet that needs to be stored in a tight container at 20°C to 25°C. The medication should be kept away from moisture and out of reach of children. The usual dosage information is available in the package insert. The product is manufactured by TWi Pharmaceuticals, Inc., Taoyuan City, Taiwan.*

FDA Label Image

Mycophenolic Acid Structural Formula. (Myfortic 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.